載入...
Pretargeted Radioimmunotherapy for Hematologic and Other Malignancies
Radioimmunotherapy (RIT) has emerged as one of the most promising treatment options, particularly for hematologic malignancies. However, this approach has generally been limited by a suboptimal therapeutic index (target-to-nontarget ratio) and an inability to deliver sufficient radiation doses to tu...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Mary Ann Liebert, Inc.
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2936263/ https://ncbi.nlm.nih.gov/pubmed/20423225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2010.0759 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|